2m 2m 2m 2m 2m 2m 2m
Ocular Therapeut (OCUL)
NASDAQ
$10.69+$0.20 (+1.90%)
Price as of Sep 11, 2026 7:56 PM EDT- $2.3BMarket Cap
- -18.11%1-Year Change
- BiotechnologyIndustry
Ocular Therapeut (OCUL)
$10.69+$0.20 (+1.90%)
Earnings Score
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 20.78% | ||
12-Month Momentum | -19.89% | ||
3-Month Risk Adjusted Momentum | 97.13% | ||
12-Month Risk Adjusted Momentum | -28.81% |
True Yield
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.03% |
Financial Health Score
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 3 |